Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis WorldwideSalvatore Piano, Tae Hun Kim, Mónica Marino et al.|Gastroenterology|2018Cited by 513
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao‐Chun Hsu, Mindie H. Nguyen, Dae Won Jun et al.|Hepatology International|2022Cited by 27
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B studyLung‐Yi Mak, Mindie H. Nguyen, Joseph Hoang et al.|Hepatology International|2021Cited by 23
Determinants of clinical response to empirical antibiotic treatment in patients with cirrhosis and bacterial and fungal infections—Results from the ICA “Global Study” (EABCIR-Global Study)Rakhi Maiwall, Salvatore Piano, Virendra Singh et al.|Hepatology|2023Cited by 19
Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational StudyMoon Haeng Hur, Jeong‐Hoon Lee, Min Kyung Park et al.|The American Journal of Gastroenterology|2023Cited by 13